Donald McDonnell, PhD, Glaxo-Wellcome Professor of MCB and Chairman, Department of Pharmacology and Cancer Biology at Duke Cancer Institute, describes his research on a particular type of cholester
The Department of Pathology and Laboratory Medicine, in conjunction with the Abramson Cancer Center, is at the leading edge of personalized medicine with its Center for Personalized Diagnostics and
